A bill to require manufacturers of drugs to post the names of the countries in which their drugs are manufactured on their internet websites.
United States115th CongressS-3105Senate
Updated: Jun 21, 2018
Summary
Pharmaceutical Origin Transparency Act of 2018 This bill amends the Federal Food, Drug, and Cosmetic Act to require a drug manufacturer to publish information about each country in which its drugs are manufactured. (A drug is manufactured in a country if the active pharmaceutical ingredient is manufactured in such country.)
Bill texts
All available records shown.
Timeline
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Senate
All available records shown.